新的癌症亚型识别方法以瘤正常样本为指导,用于转录基因变异自编码器的潜空间
Hongzhi Wang1, Yu Zhang1, Dandan Zhang1
1The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Scientific reports
|July 21, 2025
概括
这项研究引入了VaDTN,这是一个新的框架,用于分析瘤和正常组织. 它识别癌症亚型和生存差异,提供新的精确瘤学策略.
科学领域:
- 计算生物学是一种计算生物学.
- 基因组学就是基因组学.
- 癌症研究 癌症研究
背景情况:
- 瘤发生涉及微观进化和复杂微观环境中的适应.
- 当前的奥米克分析往往忽略了正常组织数据,限制了对瘤演变的洞察力.
- 了解瘤异质性需要整合各种生物数据源.
研究的目的:
- 开发一个整体癌症框架,整合瘤和正常的转录组数据.
- 识别与瘤进化和异质性相关的分子转移和亚型.
- 评估准确瘤学中以参考为中心的方法的临床相关性.
主要方法:
- 介绍了VaDTN (变量自编码器衍生的瘤到正常),这是一个新的框架.
- 从瘤和正常样本的转录组数据集成到一个统一的潜在空间.
- 从正常基准测量瘤距离,以揭示分子转移和亚型.
主要成果:
- 在6种代表性癌症类型 (SKCM,BRCA,LIHC,LUSC,STAD,PAAD) 中,VaDTN确定了不同的癌症亚型.
- 亚型的特征是独特的转录形状.
- 根据VaDTN衍生的亚型,在四种癌症类型 (SKCM,BRCA,LIHC,STAD) 中观察到显著的生存分层.
结论:
- VaDTN框架为剖析瘤内多样性提供了一个精细的,以参考为中心的视角.
- 整合正常组织数据可以提高对瘤进化和异质性的理解.
- 这种方法对指导精确瘤学策略具有潜在的临床意义.
相关概念视频
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


